Management of bleeding in the terminally ill patient

Hematology

Volumn 10, Issue 3, 2005, Pages 167-175

  Prommer, Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bleeding; Cancer; Terminal illness; Therapy

Indexed keywords

ACETONE; ADRENALIN; ALUMINUM POTASSIUM SULFATE; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ASTRINGENT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CHOLINE MAGNESIUM TRISALICYLATE; COCAINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DESMOPRESSIN; FIBRIN GLUE; FORMALDEHYDE; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; MELATONIN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILVER; SILVER NITRATE; SUCRALFATE; THROMBIN; TRANEXAMIC ACID; VITAMIN K GROUP; VON WILLEBRAND FACTOR; WARFARIN;

ARGON PLASMA COAGULATION; BLEEDING; BLOOD CLOTTING DISORDER; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CANCER INVASION; CAREGIVER; CELL TRANSPLANTATION; CHEMOEMBOLIZATION; CLINICAL TRIAL; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ACTIVITY; DYSFIBRINOGENEMIA; ENDOSCOPY; EPISTAXIS; FAMILY COUNSELING; FIBRINOLYSIS; HEART ARRHYTHMIA; HEMOPHILIA; HUMAN; HYDROGEL; KAPOSI SARCOMA; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; MALABSORPTION; MERKEL CELL TUMOR; MUCOSA INFLAMMATION; MYCOSIS FUNGOIDES; NECK CANCER; NUTRITIONAL DEFICIENCY; PALLIATIVE THERAPY; PATIENT POSITIONING; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; T CELL LYMPHOMA; TERMINAL DISEASE; TERMINALLY ILL PATIENT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRANSPARENT DRESSING; VAGINA BLEEDING; VALVULAR HEART DISEASE; VITAMIN K DEFICIENCY; VON WILLEBRAND DISEASE; WOUND DRESSING; YAG LASER; CLASSIFICATION; ETHICS; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT CARE; TERMINAL CARE;

ADVANCE CARE PLANNING; HEMORRHAGE; HUMANS; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE; TERMINAL CARE; TERMINALLY ILL;

EID: 25144469682     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500093237     Document Type: Review

References (62)

1. Gagnon B, Mancini I, Pereira J, Bruera E. Palliative management of bleeding events in advanced cancer patients. J Palliat Care 1998;14:50-54.
2. Friedman KD, Raife TJ. Management of hypercoagulable states and coagulopathy. In: Berger A, Portenoy R, Weissman D, editors. Principles and practice of palliative care and supportive oncology. Philadelphia, Penn: Lippincott Williams and Wilkens; 2002. p 452-462.
3. MacDougall R, Munro AJ, Wilson Janet A. Palliation in head and neck cancer. In: Geoffrey DD, Hanks WC, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: England Oxford Medical Publications; 1999. p 677-689.
4. Citardi MJ, Chaloupka JC, Son YH, Ariyan S, Sasaki CT. Management of carotid artery rupture by monitored endovascular therapeutic occlusion (1988-1994). Laryngoscope 1995;105:1086-1092.
5. Kvale PA, Simoff M, Prakash UB. American College of Chest Physicians. Lung cancer. Palliative care. Chest 2003;123(suppl 1):284S-311S.
6. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.
7. Croom KF, Perry CM. Imatinib mesylate: In the treatment of gastrointestinal stromal tumours. Drugs 2003;63(5):513-522, discussion 523-4.
8. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480.
9. Akriviadis EA. Hemoperitoneum in patients with ascites. Am J Gastroenterol 1997;92:567-575.
10. Okuda K. Hepatocellular carcinoma: Clinicopathological aspects. J Gastroenterol Hepatol 1997;12:S314-S318.
11. Zhu LX, Wang GS, Fan ST. Spontaneous rupture of hepatocellular carcinoma. Br J Surg 1996;83:602-607.
12. Capizzi PJ, Donohue JH. Metastatic melanoma of the gastrointestinal tract: A review of the literature. Compr Ther 1994;20:20-23.
13. Mercadante S, Fusco F, Valle A, Fulfaro F, Casuccio A, Silvestro S, Donelli. Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home. Support Care Cancer 2004;12(2):95-98.
14. Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk Res 2003;27:481-488.
15. Peterson DE, Cariello A. Mucosal damage: A major risk factor for severe complications after cytotoxic therapy. Semin Oncol 2004;31(3 Suppl 8):35-44.
16. Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol 2004;41(1 suppl 1): 93-100.
17. Weber M, Kroger N, Langer F, Hansen A, Zabelina T, Eifrig B, Hossfeld DK, Zander AR. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;31:817-822.
18. Dunn A, Carter J, Carter H. Anemia at the end of life: Prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manag 2003; 26(6):1132-1139.
19. Stefanini M. Cutaneous bleeding related to zinc deficiency in two cases of advanced cancer. Cancer 1999;86:866-870.
20. Johnson MJ. Problems of anticoagulation within a palliative care setting: An audit of hospice patients taking warfarin. Palliat Med 1997;11:306-312.
21. Bick RL, Strauss JF, Frenkel EP. Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am 1996;10:875-907.
22. Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N, Martinelli G, Ottaviani E, Testoni N, Nocentini F, Pastano R, Piccaluga P, Isidori A, Grafone T, Tura S. All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia. Eur J Haematol 2000;64:139-144.
23. Chung CY, Hsu NC, Horng HC, Chang CS. Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia. Leuk Lymphoma 2003;44:1059-1061.
24. Meijers JC, Oudijk EJ, Mosnier LO, Bos R, Bouma BN, Nieuwenhuis HK, Fijnheer R. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. Br J Haematol 2000;108:518-523.
25. Kohli M, Kaushal V, Mehta P. Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 2003;29:301-308.
26. Kothari P, Patel SK, O'Malley S. Application of cocaine to the nasal mucosa: A novel method. J Laryngol Otol 2001;115:650-651.
27. Patsner B. Topical acetone for control of life-threatening vaginal hemorrhage from recurrent gynecologic cancer. Eur J Gynaecol Oncol 1993;14:33-35.
28. Fletcher H, Wharfe G, Mitchell S, Simon T. Treatment of intractable vaginal bleeding with formaldehyde soaked packs. J Obstet Gynaecol 2002;22:570-571.
29. Parikh S, Hughes C, Salvati EP, Eisenstat T, Oliver G, Chinn B, Notaro J. Treatment of hemorrhagic radiation proctitis with 4 percent formalin. Dis Colon Rectum 2003;46:596-600.
30. Adebamowo CA. Topical formalin for management of bleeding malignant ulcers. World J Surg 2000;24:518-520.
31. Cotti G, Seid V, Araujo S, Souza Jr, AH, Kiss DR, Habr-Gama A. Conservative therapies for hemorrhagic radiation proctitis: A review. Rev Hosp Clin Fac Med Sao Paulo 2003;58:284-292, Epub 11.
32. Regnard CF. Control of bleeding in advanced cancer. Lancet 1991;337:974.
33. Segal HC, Hunt BJ, Gilding K. The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation. J Biomater Appl 1998;12:249-257.
34. Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003;112:73-82.
35. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: Bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 2004;13(suppl 1):S89-S96.
36. Lagman R, Walsh D, Day K. Oxidized cellulose dressings for persistent bleeding from a superficial malignant tumor. Am J Hosp Palliat Care 2002;19:417-418.
37. Chapman WC, Wren SM, Lebovic GS, Malawer M, Sherman R, Block JE. Effective management of bleeding during tumor resection with a collagen-based hemostatic agent. Am Surg 2002;68:802-807.
38. Kanaoka Y, Hirai K, Ishiko O, Ogita S. Vesicovaginal fistula treated with fibrin glue. Int J Gynaecol Obstet 2001; 73:147-149.
39. Hanif J, Tasca RA, Frosh A, Ghufoor K, Stirling R. Silver nitrate: Histological effects of cautery on epithelial surfaces with varying contact times. Clin Otolaryngol 2003;28:368-370.
40. Lowe BA, Stamey TA. Endoscopic topical placement of formalin soaked pledgets to control localized hemorrhage due to radiation cystitis. J. Urol 1997;158:528-529.
41. Choong SK, Walkden M, Kirby R. The management of intractable haematuria. BJU Int 2000;86:951-959.
42. Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med 2003;29:317-320.
43. Cross CK, Berman S, Buswell L, Johnson B, Baldini EH. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy X 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004; 58:1098-1105.
44. Onsrud M, Hagen B, Strickert T. 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecol Oncol 2001;82:167-171.
45. Panizzon RG. Radiotherapy of skin tumors. Recent Results Cancer Res 2002;160:234-239.
46. Wong R, Thomas G, Cummings B, Froud P, Shelley W, Withers RH, Williams IJ. The role of radiotherapy in the management of pelvic recurrence of rectal cancer. Can J Oncol 1996;6(suppl 1):39-47.
47. Yingna S, Yang X, Xiuyu Y, Hongzhao S. Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. Gynecol Oncol 2002;84:416-419.
48. Ray CE, Jr. Interventional radiology in cancer patients. Am Fam Physician 2000;62:95-102.
49. Pisco JM, Martins JM, Correia MG. Internal iliac artery: Embolization to control hemorrhage from pelvic neoplasms. Radiology 1989;172:337-339.
50. Savides TJ, Jensen DM. Therapeutic endoscopy for non-variceal gastrointestinal bleeding. Gastroenterol Clin North Am 2000;29:465-487.
51. von Ditfurth B, Buhl K, Friedl P. Palliative endoscopic therapy for rectal cancer with neodymium: YAG laser Eur. J Surg Oncol 1990;16:376-379.
52. Birnbaum PL, Mercer CD. Laser fulguration for palliation of rectal tumours. Can J Surg 1990;33:299-301.
53. Kimmey MB. Endoscopic methods (other than stents) for palliation of rectal carcinoma. J Gastrointest Surg 2004;8:270-273.
54. Callow CR, Swindell R, Randall W, Chopra R. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. Br J Haematol 2002;118:677-682.
55. Wandt H, Ehninger G, Gallmeier WM. New strategies for prophylactic platelet transfusion in patients with hematologic diseases. Oncologist 2001;6:446-450.
56. Lassauniere JM, Bertolino M, Hunault M, Zittoun R, Verspieren P, Moh-Klaren J, Jaulmes D, Colombat P. Platelet transfusions in advanced hematological malignancies: A position paper. J Palliat Care 1996;12:38-41.
57. Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer 2002;10:110-116, Epub 2001 Nov 13.
58. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(suppl 3):204S-233S.
59. Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F. Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. Haematologica 1997;82:584-587.
60. Sajdak S, Moszynski R, Opala T. Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII. Eur J Gynaecol Oncol 2002;23:325-326.
61. Dean A, Tuffin P. Fibrinolytic inhibitors for cancer-associated bleeding problems. J Pain Symptom Manag 1997;13:20-24.
62. Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I. A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. Leuk Lymphoma 1995;19:141-144.